Eli Llly: Orfoglipron/LY3502970/ Formerly Chugai OWL833 Orfoglipron is an oral GLP1R agonist , taken daily due to its half life of 25-68 hours [28]
AMA Special AMA: Peter on exercise, important labs, building good habits, promising longevity research, and more #329 Special AMA: Peter on exercise, important labs, building good habits, promising longevity research, and more In this special episode of The Drive, Peter tackles a wide range of listener questions submitted over the past year
Additionally, it may positively influence metabolism, promoting more efficient energy use
Men with obesity or type 2 diabetes should speak to their GP about currently NICE-approved options such as semaglutide (Wegovy) or tirzepatide (Mounjaro) while trials continue